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ABSTRACT OF THESIS
Synthesis of HuaCat® Analogues as Novel Organocatalyst for the Formation of
Asymmetric Carbon-carbon Bonds
by
Kenneth Laboy
Master of Science, Graduate Program in Biochemistry
Loma Linda University, September 2016
Dr. David J. Weldon, Chairperson

The synthesis of organic compounds with preferential stereochemistry is
ubiquitous in the scientific community. A chemical reaction that asymmetrically induces
one stereoisomer over another is achieved through the use of catalysts and various
coupling reagents.1 Inorganic catalysts, such as TiCl4 and ZnCl2, have been documented
for many decades as effective agents in the synthesis of asymmetric bonds, however,
there are environmental limitations to their use. First, the asymmetric reactions involving
these metal catalysts require solvents that are not environmentally-friendly, especially
when used on an industrial scale and second, the metal catalysts are recycled when
possible, however, there is always metal waste that is equally unfriendly to the
environment. One solution is to develop organocatalysts (non-metal catalyst) that will
accomplish the same asymmetric reactions in aqueous reaction conditions. HuaCat® and
HuaCatII® are organocatalysts developed by Dr. Rich Carter at Oregon State University
that are able to achieve a single stereochemistry in 98% yield with greater than 95%
diastereomeric excess.2, 3 These catalyst are not metal-containing and do work in aqueous
conditions, but they still require the use of some solvent. The development of analogues
of HuaCat® by substituting aromatic substituents with different electron
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withdrawing/donating groups will afford catalysts with increased yield and more
predictable stereochemistry in aqueous conditions. One of the major challenges of the
project is the formation of the key peptide bond of an amino acid and a sulfonamide
containing a highly electronegative aromatic substituent in the ortho position, a feat that
has minimal (and questionable) literature support to date. In this paper, we will detail the
methods that have been attempted and the future plans for overcoming this unfavorable
reaction to achieve what could be a new path to a unique organic structure for further
synthetic manipulation.

xv

CHAPTER ONE
INTRODUCTION

The Importance/Significance of Carbon-Carbon Bond Formation
Carbon-carbon (C-C) bond formation is the foundation to organic life here on
earth.4 Any attempt to understand and expand upon the properties of organic life start
with reactions of organic compounds and is further preceded by their chemical structure.5
Biomedical translational research hopes to convert what the scientist elucidates in the
laboratory into practical application that can be employed in a clinical setting for organic
life;6 therefore, it is explicit that the two fields have cohesion. The focus of this thesis will
be intrinsic carbon-carbon bond forming activities in nature and the organic synthetic
processes utilized to make novel structures with biological importance.
Nature affords a large number of structurally diverse compounds capable of
regulating many biological processes, including cell division, differentiation and
enlargement, chloroplast development and senescence. In order to access compounds
with improved properties in comparison to those found naturally-occurring, it is essential
to establish their structure-activity relationship (SAR). SAR research area in organic
chemistry entails defining the role of the molecular features of any biologically-active
chemical structure with respect to its target.7 SAR research involves the construction of a
diverse and systematic library of derivatives that can then be compared to a
pharmacophore model of the natural product to determine the role of the manipulated
areas defined by the derivative library.8 A pharmacophore is defined by Yang as “the
ensemble of steric and electronic features that is necessary to ensure the optimal supramolecular interactions with a specific biological target and to trigger (or block) its
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biological response.”9 In other words, the pharmacophore is the minimal molecular
features of any biological compound that are absolutely necessary to appreciably interact
with the target. Defining a pharmacophore for a class of therapeutics is an early and
essential step of translational research and modern drug discovery has an intense demand
for stereoselective transformations of potential drug candidates.10 The search for potential
pharmacophores has necessitated the use of catalysts that can facilitate the synthesis of
natural products and their derivatives.11 Leading to the rational observation that the
pioneering of effective synthetic organic catalysts that can stereo- and regioselectively
manipulate favorable chemical reactions with high product yields, minimal cost, and
minimal environmental implications is fundamental to the scientific and health
community.
Organic synthesis can be divided into various categories with two main types of
reactions: C-C bond formations and functional group transformations.12 C-C bond
formation is the core of organic synthesis13 and furnishes the basis for producing more
intricate organic compounds from simpler ones. The ability to manipulate the carbon
backbone of various organic molecules through C-C bond formation makes it one of the
cornerstones to transformation in organic synthesis.14 It is fundamental in medicinal
chemistry to have the capability to expound and develop the carbon framework of
organic molecules via a series of C-C bond forming reactions.15 Its function in nature for
biosynthesis and metabolism is critical to the survival of organic lifeforms in order to
maintain homeostasis.16 Moreover, it can be applied to organometallic17, agrochemical18,
and biocatalytic organic synthesis.19
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In nature, organic substances found in living organisms are conceived innately.
Molecules from nature are essentially blueprints for organic chemists to develop novel
techniques for determining structures, analyzing mechanisms of reactions, exploring the
effects conformation and stereochemistry have on reactions, and pioneering challenging
new targets to synthesize.20 Harnessing the powerful techniques of organic molecules in
their biological hosts, such as the enzymes that synthesize endogenous molecules and the
complex processes that occur in a cell, is a valuable tool.15 In this congruent perspective,
bioorganic chemistry hopes to understand the chemical mechanisms of enzyme-catalyzed
reactions, to develop techniques to identify and to study how structure determines
function in biosynthetic enzymes20 with protein substrates obtained by organic synthesis
through the use of catalyzed C-C bond formation.21
Expanding on the importance of C-C bond formation leads to a focus on
biochemical enzymatic reactions, which are often overlooked as a method for organic
synthesis of C-C bond formation. Biochemical reactions are generally catalyzed by an
enzyme and are classified in one of these four broad categories: (1) group-transfer
reactions, (2) oxidation and reductions, (3) eliminations, isomerizations, and
rearrangements, and (4) reactions that make or break carbon-carbon bonds.20 It is noted
that elimination reaction mechanisms using dehydration resulting in the formation of a
C=C double bond (e.g. enolase, fumarase) should be considered C-C bond formation;22
The focus of this research project is primarily C-C bond formation, the fourth category of
biochemical enzymatic reactions.
There are many examples of catalysis in biological processes. One example are
aldolases, a class of enzymes that act as catalysts for aldol condensation reactions.23 An
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aldol condensation is an organic chemical reaction in which an enol, or an enolate ion,
reacts with a carbonyl compound to form a β-hydroxyaldehyde or β-hydroxyketone,
followed by a dehydration step to yield a conjugated enone (Figure 1).24

Figure 1 - General Aldol condensation reaction

In the first step of the Krebs cycle, citrate synthase catalyzes the reaction of acetyl
coenzyme A (acetyl CoA) and oxaloacetate to produce citrate through an aldol
mechanism (Figure 2). In this specific reaction, it is not an aldehyde or a ketone that acts
as the nucleophile as shown in Figure 1, but rather thioester Acetyl-CoA.25 Generally
speaking Biochemists refer to this reaction as an aldol condensation reaction describing
the first step of the process, the addition initiated by base deprotonation of an α-Hydrogen
from acetyl CoA forming an enolate nucleophile that subsequently attacks the
electrophilic carbonyl carbon of Oxaloacetate ion. Protonation eventually leads to the
final product with the generation of a new C-C bond and a new stero-center.26

Figure 2 - Citrate synthase aldol condensation reaction of the first step of the Krebs cycle
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Another example of this particular reaction takes place in gluconeogenesis. The
reaction between two 3-carbon containing sugars, specifically glyceraldehyde-3phosphate (GAP) and dihydroxyacetone phosphate (DHAP), to form the six-carbon
product fructose 1, 6-bisphosphate (F1,6-BP) (Figure 3). This reaction is catalyzed by
the enzyme fructose 1,6-bisphosphate aldolase.25 It must be noted that the aldol reaction
is not formally a condensation reaction because it does not involve the loss of a small
molecule, however, it is an important example where a catalyzed C-C bond formation is
used in biochemistry, thereby alluding to its significance in nature.

Figure 3 - Aldolase catalyzed reaction of GAP & DHAP

Steroids present another example of C-C bond formation in nature. Steroid
biosynthesis is an anabolic pathway which produces steroids from simple precursors.
Following the biosynthetic pathway in animals is a common method for drug
development of targets for antibiotics and other anti-infection drugs.9, 27 Steroid
metabolism in humans is also the target of cholesterol-lowering drugs.9, 13 The
biosynthesis of steroids flows through the mevalonate pathway, which uses acetyl-CoA
as building blocks to make lanosterol, a precursor to steroids found in animals, fungi, and
plants.25, 27 In the mevalonate pathway, or the HMG-CoA reductase pathway, isoprene
units donated by intermediates, isopentenyl pyrophosphate (PP or IPP) and dimethylallyl
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pyrophosphate (DMAPP), that were formed by acetyl-CoA subunits are coupled into
more complex compounds making squalene.27 These compounds are then folded and
rearranged into lanosterol for subsequent steroid biosynthesis (Figure 4). The coupling of
these small subunits into larger more complex compounds is done through enzymatic
catalysis of C-C bond formation.

Figure 4 - Biosynthesis of lanosterol from acetyl-CoA building blocks

While many processes in nature use organic-based catalysts known as
organocatalysts, organometallic reactions leading to the formation of new C-C bonds are
commonly used in synthetic organic chemistry. There are two classes of note that can be
distinguished.17 The first is when the metal acts as a template that mediates the incidence
of a peripheral reagent on a ligand without that reagent bonding within the coordination
sphere. The reaction of electrophiles with iron acylate anions,28 seen in figure 5A, and
catalytic allylic alkylation utilizing palladium complexes,29 seen in figure 5B, are a few
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well-known examples. These correspondingly exhibit enriched reactivity and
stereoselectivity via the contribution of organometallic complexes. In the second type, the
new bond is fashioned amid ligated species and a supplementary subdivision is essential.
The significant step may be cis-ligand movement, for which the most recognizable
illustration is alkyl migration to coordinated carbon monoxide (CO) in catalytic
hydroformylation. The C-C bond is established by coupling adjacent carbon-metal bonds
associated with exclusion of the organic portion.17

Figure 5 – Metal catalyst working as framework for C-C bond formation

Organometallics afford practical applications in many catalytic processes, most
notably those applications involving CO and polymers originating from alkenes.
Common manufacturing, such as polyethylene and polypropylene (types of rubber), are
produced by means of organometallic catalysts, typically heterogeneously by the use of
Ziegler-Natta30 catalysis (Figure 6).31 The carbonylation of methanol catalyzed by
iridium to acetic acid is an efficient process proclaimed by BP Chemicals using metal
carbonyl catalysts as well.32-34 Generally, synthetic aldehydes are fabricated by means of
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hydroformylation. Additionally, organic lithium (Li), magnesium (Mg), and aluminum
(Al) compounds are highly basic reducing agents that catalyze various polymerization
reactions.35 Furthermore, organometallic compounds are also used in the fabrication of
semiconductors.31 In addition to the diverse applications, organocatalysis often produces
reactions with desirable quantitative yields.29, 36 Although, in organometallic reactions,
the conversion of product is obtained in respectable yield, generally a mixture of isomers
are obtained.29, 36, 37 However these processes use volatile compounds such as trimethylgallium, trimethyl-indium, trimethyl-aluminum, as well as related nitrogen, phosphorus,
arsenic, and antimony compounds. Although found in the environment, they can be
toxically hazardous when used in these quantities in industrial purposes.38, 39

Figure 6 - Ziegler-Natta catalysis of isoprene units to form polymers such as rubber

Agricultural, as well as environmental chemistry, is also greatly impacted by
organic chemical reactions. While nature has used monohydrogenase and other enzymes
to functionalize alkanes in aqueous environments at ambient conditions,40 alkanes are
generally considered nonreactive in conventional organic chemistry.12 The direct
functionalization of alkanes is ubiquitously found in a variety of related fields including

8

the development of laboratory chemicals, energy, and medicine; therefore, chemical
synthesis of alkanes has essential implications. Research in this area predominantly
focuses on the conversion of a C-H bonds into a C-O bond. An example in Figure 7
illustrates the coupling of methane with CO to produce acetic acid in aqueous conditions
catalyzed by Ytterbium(III) acetate and sodium hypochlorite. 41 Moreover, the
application of organic synthesis of the catalytic reaction of C-H bonds adjacent to
heteroatoms such as nitrogen and oxygen.42

Figure 7 - Catalyzed carboxylation of methane to acetic acid with carbon monoxide in water

Another area where C-C bond formation is applied is in the utilization of carbon
dioxide (CO2). CO2 constitutes a natural source of carbon and a one-carbon (Cl) synthetic
component with a capacity for the functionalization of substrates.37 Unfortunately,
incorporation of CO2 into unsaturated hydrocarbons is difficult because of its molecular
stability and therefore requires activation that can be imparted through the use of
transition metal catalysts.43 Figure 8 illustrates the activation of dienes by palladium
complexes and direct incorporation of CO2 into alkynes.
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Figure 8 - Palladium catalyzed synthesis of Lactones using CO 2 and activated dienes

This is one catalytic route in which unsaturated lactones, a common intermediate
in many synthetic schemes, are made.44 Additionally, vinyl-carbamates can be
regioselectively produced in one-step from terminal alkynes, CO2, and secondary amines
with ruthenium catalysts (Figure 9).45

Figure 9 - Ruthenium catalyzed synthesis of Vinyl-carbamates

The Significance of a Broad Selection of Catalysts and Reagents
There are a wide variety of organic (non-metallic) catalytic reagents for
traditional C-C bond formations. For example, Wittig reactions use phosphonium salts
and phosphonates are used for Horner-Wadsworth-Emmons (HWE) reactions.46 Both of
these reactions are utilized to create alkene-containing products.47 However, synthetic
methods accessible for C-C bond formation are continually advancing.
There are various contributing factors that affect innovation, such as the
expansion of stout and dependable protocols for cross-coupling, augmented obtainability
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of various organometallic reagents, and the continued development of stoichiometric
reagents that facilitate the addition of a specific carbon-containing moiety. The last
category, depends on a diverse selection of reagents that can be employed under mild
conditions with a broad substrate scope. Therefore, further development of reagents that
permit potent routes to carbon-carbon bond formation is necessary. Cross-coupling
reactions make use of substrates with favorable yields in diverse reaction conditions, as
well as metal catalysts for various reactions. Research success hinges on the ability of the
researcher to obtain the desired product, which is aided by the availability of reagents that
consistently yield high specificity, when the experiment calls for it.47
Though enzymatic processes in nature are obligated to occur in an aqueous
environment by necessity, water has been a solvent to be evaded for conventional organic
reactions. The increased acknowledgment that organic reactions can move forward
suitably in aqueous media and extend improvements over those taking place in organic
solvents is widespread in the scientific community.48 This assertion was preceded by
studies into Diels-Alder reactions forged by Breslow49 and hydroformylation reactions.5052

The advent of the field of green chemistry has encouraged the expansion of
research activities in this subject matter.53 Initial curiosity has developed into a lucrative
discipline that companies have invested in with profound returns.54 This takes form by
way of an increase in stereoselectivity that benefits the researcher when designing
synthetic routes for experimental protocols, as well as the added bonus of milder reaction
conditions.55 Also, contributing to a decrease in consumable materials that leads to
increased profit margins.53 Moreover, this affords the added benefit of decreasing the
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amount of waste produced when manufacturing large scale chemical products, thereby
limiting harmful effects to the environment.56, 57 This contributed to advancement toward
comprehending the reactions of organic compounds in high-temperature water, which has
obvious implications to chemical synthesis that extends to energy and fuels.58 Green
chemistry seeks to reduce chemical related impact on human health and the environment
by the use of alternative, environmentally friendly processes and reaction media.53
The decrease in consumable materials affects two areas: Solvent and reagent
usage. The selection of solvents, the chemicals used to dissolve substances into a
solution, are a significant aim for Green Chemistry programs. The foremost source of
industrial waste in industrial chemical production comes from solvents, but meticulous
selection can also raise reaction rates and reduce reaction temperatures. Reduction in the
amount of organic solvent consumed in the synthesis of Viagra™ (Sildenafil Citrate) is a
major triumph of Green Chemistry as well as shareholders at Pfizer in the UK.59
Through innovation, organic chemists were able to make the synthesis of
Sildenafil Citrate, the active ingredient in Viagra™ and Revatio™, more efficient. The
improvements resulted in substantial environmental advantages, that brought about the
decline in the amount of several organic solvents essential for the synthesis of sildenafil
citrate.55 The utter removal of all chlorinated and highly volatile solvents such as diethyl
ether, dichloromethane, methanol and acetone. This innovation also allowed for the
removal of tin (II) chloride from the synthesis, a known environmental polluter.53 It was
replaced by a catalytic hydrogenation reaction with water being the principal by-product.
The new route was designed around a specific cyclisation reaction seen in the final step
of the synthesis ensuring a higher quality product. The financial gains can be estimated
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through the elimination of 30,000 tons of chemical solvent that are no longer needed and
decrease in the chemical reagents and substrates necessary to produce the final product.53
Essentially, the amount of product produced was increased with less reactants consumed.
Another example comes from the scale up of the synthesis of pregabalin
(Lyrica™), a medication utilized in the treatment of neuropathic pain.54 Organic chemists
remodeled the route of several enzymatic reactions to allow for chemical reactions to be
performed in water instead of organic solvents. In this occasion, a synthetically produced,
endogenous catalyst, lipase, was used. Thereby reducing the amount of organic materials
consumed. Environmentally this enzymatic process was calculated to eliminate more than
3 million tons of CO2 emissions relative to the previous industrial process. This equates
to the removal 1,000,000 cars per year off the road in the United Kingdom (UK).53

Various Methods of Carbon-Carbon Bond Formation
In the field of natural product synthesis, there are a number of methods at our
disposal to make C-C bonds. Chronologically, five separate reactions in the field of
organic chemistry have facilitated the practical use of synthetic organic reactions in the
scientific community: Michael Additions, Mannich reactions, Diels-Alder reactions,
HWE reaction, and Suzuki-Negishi (S-N) coupling reactions.
The Michael addition, introduced by Arthur Michael in 1887,60 is a facile reaction
for conjugate addition of a nucleophile and an activated olefin, or alkyne, for nucleophilic
C-C multiple bond formation (Figure 10).61 The Michael addition has various advantages
for the strategic planning of organic synthesis such as its use under mild reaction
conditions and elevated functional group tolerance. It has a broad range of use for
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polymerizable monomers and functional precursors as well as superior conversions with
favorable reaction rates.62 Furthermore, its application in post-polymerization
modification63 and coupling of biological and synthetic polymers is well documented.64
The Michael addition reactions versatility makes it well-suited to numerous types of
laboratory disciplines to include biomedical applications such as gene transfection,65 cell
scaffolds,66 and tissue replacements.62
The convenience it affords over other reactions stems from facilitation of a wide
range of polymers from assorted monomers, and analogous polymers are formulated in
environments in which competing polymerization mechanisms will not function as well.
This makes it valuable in biological applications, for instance, in protein derivitization the
Michael additions mild reaction conditions are favorable since high temperatures,
oxidizing radicals, and organic solvents are not possible.21
As aforementioned, the Michael addition encompasses the addition of a
nucleophile, or ‘donor,’ to an activated electrophilic olefin, the ‘acceptor,’ resulting in a
‘adduct.’ It is generally considered in reactions where the addition of enolate
nucleophiles to activated olefins is wanted; however, there are multiple functional groups
that possess sufficient nucleophilicity to operate in the same capacity, as ‘Michael’
donors. Reactions containing non-enolate nucleophiles such as amines, thiols, and
phosphines are classically referred to as ‘Michael-type’ additions. As long as the acceptor
possesses an electron withdrawing and resonance stabilizing activating group that
stabilizes the anionic intermediate, it can be considered a Michael addition.67 There are
many ‘Michael-type’ acceptors, because many functional groups have the electron
withdrawing activating effect necessary to integrate seamlessly in Michael addition
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reactions,68 and are readily available commercially.47 Examples are: Acrylamides, vinyl
sulfones, α,β-unsaturated aldehydes, and azo compounds, to name a few.67

Figure 10 - Michael addition reaction

The use of organic synthesis to produce natural endogenous compounds is quite
prevalent and one such reaction employed to do so is the Mannich reaction, presented by
Carl Mannich in 1912.69 The synthesis of various compounds such as peptides,70
nucleotides,71 antibiotics,72 and compounds that contain high concentrations of amines,
such as alkaloids,11 are all methods in which Mannich reactions are typically used.73
Furthermore, it is commonly used in agrochemistry to synthesize endogenous auxins,11 to
establish quantitative structure-activity relationships, and analogous derivatives with
improved properties to pioneer novel ligands compare pharmacophore model capacity.
The Mannich reaction is a condensation reaction considered to be a paradigm of
nucleophilic addition of a primary or secondary amine to a carbonyl functional group,
leading to subsequent dehydration to the Schiff base. The second step involves the
electrophilic addition of the Schiff base with a compound possessing an acidic proton.74
Essentially, it involves the addition of resonance-stabilized carbon nucleophiles to a
substituted imines, or iminium salts. The carbonyl containing compound can undergo
tautomerization to the enol form and subsequent attack of the protonated imine. The
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Mannich reaction consists of three elements: (1) a primary or secondary amine; (2) an
aldehyde; and (3) a methylene bridge,75 a functional group that withdraws electrons by
resonance.71 Condensation of the reactants takes place with concomitant discharge of
H2O. This leads to the production of a ‘Mannich base’, where the active hydrogen is
supplanted by an amino-methyl group.71 A general reaction scheme can be seen in figure
11.

Figure 11 - Mannich reaction

The Diels–Alder reaction is yet another applicable form in which C-C bond
formation is fundament in research. It is the organic chemical reaction between a
conjugated diene and a substituted alkene, ordinarily dubbed the dienophile, to form
substituted cyclic systems.76 In 1950, the Nobel Prize in Chemistry was awarded to Otto
Diels and Kurt Alder for their introduction of this reaction in 1928.77 Typically, the
Diels–Alder reaction is acutely useful in synthetic organic chemistry as a dependable
method for forming 6-membered systems with respectable management over regio- and
stereochemical properties.78 The underlying concept has also been applied to other πsystems, such as carbonyls and imines, to furnish the corresponding heterocycles, known
as the hetero-Diels–Alder reaction.79, 80 A general reaction scheme can be seen in figure
12.
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Figure 12 - Diels-Alder reaction

Diels–Alder reactions are another valuable tool for the formation of C-C bond
formation used in total synthesis of endogenous steroids, such as cortisone and
cholesterol.81 Butadiene’s reaction with quinone derivatives is essential to produce
steroid skeleton rings with the sought after regiochemistry. Prostaglandins are another
endogenous compound synthetically made that makes use of a Diels–Alder reaction early
in its synthesis, thereby facilitating the relative stereochemistry of adjoining stereocenters
on the prostaglandin core.82 The preceding applications justify the rational that C-C bond
formation is scientifically fundamental and beneficial to the future development of
laboratory research.
The HWE reaction is one of the tools of choice for olefination reactions in the
field of organic chemistry. It stems from Leopold Horner’s publication in 1958, of a
unique Wittig reaction that uses carbanions stabilized by phosphine-oxide and carbonyl
compounds.83 Eventually W.S. Wadsworth and W. D. Emmons were able to modify the
reaction further by applying phosphonates.84 It is prevalently used for elaborating on
complex synthetic precursors. However, it also used as a method to strategically couple
preformed sections of a target molecule. Based on the developed route is may also be
used to otherwise introduce a newly formed olefin when a defined stereochemistry is
preferred. A general reaction scheme can be seen in figure 13.
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Figure 13 - HWE reaction

Although the prevailing employment of this reaction is as a dependable means for
E-alkene formation, it must be noted that the stereochemical outcome of the reaction
depends on both the structure of the reactants and on the reaction medium. These factors
encompass the base, solvents, and the inclusion (or exclusion) of any congruent additives,
such as salts and crown ethers.85 However it has been demonstrated that Z-selectivity can
be accomplished as well using either Phosphonic acid bis(2,2,2-trifluoroethyl) ester
established by Still86 or bis(O-aryl)phosphonates offered by Ando.87 Furthermore, it is
well documented that the standard conditions originally in place can be modified as well
with adequate success.85
The palladium-catalyzed cross coupling reaction of boronic acid in the presence
of organic halides is labeled the “Suzuki coupling” and is another means by which
organic chemists are able to accomplish C-C bonds.88 The originator of this method, was
Akira Suzuki in 1979.89 Palladium-catalyzed cross couplings in organic synthesis were
pioneered by Suzuki, Ei-ichi Negishi, as well as Richard Heck, and they were jointly
awarded the Nobel Prize in chemistry in 2005 for their efforts.90 One of the differences
between the Suzuki and Negishi coupling reactions is the use of either Nickel (Ni) or
Palladium (Pd).91 Moreover, Negishi reactions are more commonly used in the synthesis
of acyclic di, tri, and higher order terpenoid systems, over Suzuki reactions.92
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Similar to HWE reactions, the Suzuki reaction is commonly employed to
synthesize poly-olefins,89 but with different substrate requirements. However, it is also
used in reactions with styrenes, a precursor to plastic,93 and substituted biphenyls are also
coupled by this method.94 It also shares the feature of its employment in the synthesis of
complex compounds from smaller ones, which is advantageous for pharmaceutical agents
in drug development.95 For example, Caparratriene is an active compound isolated from
the oil of Ocotea caparrapi tree, that is native to Colombia.96 The oil is locally used in
Colombia for remedies in treatment of a various ailments, and Cytotoxicity studies of the
oil using human leukemia cells (CEM) showed considerable inhibition of growth at
concentration when suspended in DMSO.96 The key step in the synthesis of this
compound uses the Suzuki reaction for coupling of the E-vinyl borane with E-2-bromo-2butene that successfully generated isomerically pure caparratriene.97 This infers the
practicality of this reaction in chemical synthesis of C-C bond formation.
The general scheme for the Suzuki reaction (displayed in figure 14) employs a Pd
catalyst, in the 0 oxidation state and a base, in the presence of a phosphine ligand (LnPd0)
to facilitate the coupling of a organoboron species (RBR”2) with a halide (R’X) to form a
single carbon-carbon bond.98 The reaction method is known to be less toxic and contain
more functional group tolerance than its other organometallic predecessors. While having
similar commercial availability options.99 In addition, the Suzuki coupling is quite
versatile with respect to the number of reaction conditions that it can be utilized in. For
example, running the Suzuki coupling reaction in a micellar solution using TPGS-750-M,
a designer surfactant, introduced by Bruce Lipshutz, enhances the yield and drastically
diminishes the environmental contour it produces, or E factor, of the reaction.59, 100
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Figure 14 - General Suzuki reaction scheme with ligands below and catalytic cycle with Palladium
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Stereochemistry and Regiochemistry
Although C-C bond formation is one of the foundations to organic chemical
synthesis. It must be noted that physical and molecular properties can be expressed
differently based on the stereochemistry of a compound. Furthermore how a compound
participates in a reaction is a concept of regiochemistry.
A corollary of the tetrahedral arrangement of bonds to carbon is that two
compounds may be different because the arrangement of their atoms in space is unalike.
Stereoisomers have the same constitution but differ in their atomic spatial arrangement.101
For example, in figure 15, 2-bromo-3-chlorobutane have various confirmations in which
it can assume, with some being enantiomers and others diastereomers.

Figure 15 – Example of stereoisomers using 2-bromo-3-chlorobutane; A & B, and C & D: are
enantiomers; A, & C or D: are diastereomers; B, & C or D: are diastereomers.

Although the physical properties, such as density, melting point, and boiling
point, can be relatively identical in most cases (cis- vs trans-2-butene being an
exception102). However, the difference in the relative spatial arrangement of atoms that
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form the structure of molecules governs how molecules interact and their manipulation
by other compounds in a reaction mixture.103 The enantiomeric configurations of Carvone
presents a comprehensible instance where this is made apparent (see figure 16).

Figure 16 - Structures of (R)-(-)-carvone (A), (S)-(+)-carvone (B), with IUPAC names below each

The (S)-(+)-carvone, is a major component of caraway oil and it’s enantiomer
conformation, (R)-(-)-carvone, is the primary constituent of Spearmint oil.104 Although
structurally similar, except at its chiral center, have different odors. The disparity in
expression of these two enantiomers is due to the divergence in behavior toward receptor
sites in the nose.105 These receptor sites are themselves chiral and are innately stereoselective in the compounds that they will bind with.101 This illustration shows how the
difference in stereoisomers modifies how two enantiomers accommodate to their
environment.
The high degree of chiral recognition inherent in most biological processes has
prompted a number of considerations ranging from safety and efficacy to synthetic
methodology, thereby requiring more chiral synthetic drugs become available in
enantiomerically pure form.106 Most naturally derived drugs are chiral and are already
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extracted as a single enantiomer from the source instead of as a racemic mixture.101
Although the desired therapeutic activity resides in one of the enantiomers, many
synthetically prepared drugs are administered as racemic mixtures. Although in some of
these racemic drugs, the inert enantiomer is relatively benign. In the case of over the
counter Ibuprofen, the (S) active form is responsible for the analgesic/anti-inflammatory
effects and the (R) enantiomer is inert (see figure 17 for structure). However, it is
eventually metabolically converted through Lipase enzyme-catalysis in the body to the
active (S) configuration.107

Figure 17 - Structure of Ibuprofen; (A) is the inactive form and (B) is the active form

However, this relatively benign effect is not always the case, as the frequently
documented circumstance of thalidomide. Thalidomide is a pharmaceutical drug
prescribed for the treatment of morning sickness in pregnant women108 (see figure 18 for
structure). The drug was discovered to be teratogenic, producing harmful genetic
modification to early embryonic development, leading to severe limb deformation in
neonates.109 There are various mechanisms proposed to explain the biological role for
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both the (R)- and the (S)-thalidomide enantiomers.110 Pharmacokinetically thalidomide
undergoes racemization: even if only one of the two enantiomers is administered as a
drug, the other enantiomer is produced as a result of metabolism.111 Thalidomide is
currently used for the treatment of other diseases, most notably cancer.112 This tragedy
initiated the involvement of the Food and Drug Administration to develop strict
guidelines requiring testing of drugs prior to making them accessible to the public.106
These guidelines encouraged drug design that specifically focused on methods to
synthesize the desired enantiomer, but left the option available for the approval of new
drugs as racemic mixtures under special circumstances.113

Figure 18 - Structure of Thalidamide

The implications in synthetic organic chemical reactions is because during
experiments, in the absence of other chiral molecules, reactions will generate achiral
products or racemic mixtures.101 Functional groups such as Carbocations and alkenes,
which are both planar, are attacked from either face in equal amounts generating racemic
product mixtures.114 Since the faces of the systems are equivalent and there is nothing to
distinguish them then the probability of interaction is generally the same. In order to
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create non-racemic products, a chiral influence must be used in the form of the starting
material, a reagent, a catalyst or even during purification.101 In either circumstance the
general implication is that more reliable methods to produce higher yield of
enantiomerically pure product is imperative to the organic synthesis.
Essentially, research into methods for executing syntheses of single stereoisomers
is critical due to the obligation to produce optically pure pharmaceutical products,
particularly where one enantiomer is more effective than the other.
In chemistry, regioselectivity is the process that favors bond formation at a
particular atom over another possible atom.115 The concept concerns the various probable
positions a reagent will affect a compound in a reaction procedure, such as which
Hydrogen will be deprotonated by a strong base from an organic molecule, or the most
favorable position of insertion of an additional substituent on an already substituted
benzene ring.115, 116 This application of rules associated with reaction predictability based
on the stability of a molecule relative to the point of incidence where two molecules
possibly interact. The complexity of the topic is abstract and goes beyond the scope of
this topic; therefore, the significance is better described by the description of what it
implies in organic synthetic processes. Such as the potential to impact two adjacent
carbons, like in addition reactions of C-C bond formation. In this instance, if two new
single bonds are formed from two separate atoms, then the potential to form isomers
exists and one isomeric configuration has priority over the other, or one form is the
dominant form due to regioselectivity.
The most notable concept that applies is Markovnikov’s rule117 that states, “With
the addition of a protic acid (HX) to an unsymmetrical alkene, the acid hydrogen (H)
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becomes attached to the carbon with fewer alkyl substituents, and the halide (X) group
becomes attached to the carbon with more alkyl substituents.” The basis for this rule is
the formation of the most stable carbocation during the addition process101 (see figure
19). Essentially, a positive charge is produced on the opposing carbon when a hydrogen
ion undergoes addition to one carbon atom of an alkene, forming a carbocation
intermediate. The more substituted carbon element has more stability due to induction
and hyperconjugation. The major product of the addition reaction is predicted to be the
carbocation with the most stable intermediate. However, the other less substituted, or less
stable, carbocation will still be formed, but at less appreciable yield.

Figure 19 - General example of Markovnikov addition

An example can be ring-forming reactions using Baldwin’s rules, which are
notably familiar processes in organic chemistry. The application of a set of simple rules
(or predesignated constraints) is useful in predicting the relative capability of different
ring closures; therefore, suitable preparation can negate potential problems to organic
chemists, especially in planning syntheses.118 Furthermore, these rules help to specify that
certain experiments are favored over others; which may be helpful to define more
precisely their limits. The rules are of a stereochemical nature, thus these designs benefit
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synthetic chemists in both planning syntheses and examination of unsuccessful
constructs. Which is a common occurrence in all scientific disciplines, not solely limited
to organocatalysis.
Regioselectivity extends to other disciplines as well. For example in molecular
biology cyclin dependent kinases (CDK) are central for the processes of cell division and
proliferation. Correspondingly, innovation into the development of synthetic CDK
inhibitors for the treatment of cancer and other proliferative diseases is currently being
done.119 More specifically, a report on the synthesis and inhibitory actions of purine
derivatives against CDK1 demonstrated that among these purines, the ortho hydroxyl
substituted benzyl purine displayed greater activity towards the enzyme CDK1 than its
meta and para substituted counterparts.116 Therefore the synthetic approach was designed
utilizing regioselective protection as the key step in the syntheses of the desired methyl
benzoate.
This is shown in the reaction procedure by acylation of a compound
predominating at hydroxyl groups that were meta and para to the carbomethoxy group
and not the ortho substituted hydroxyl group of the benzoic acid substrate to be modified.
Therefore, protecting groups120 were introduced to the meta and para substituted hydroxyl
groups to destabilize their reactive intermediates, ameliorating their regioselectivity in the
reaction. The steric hindrance between the bulky protecting groups on the meta and para
positions facilitated favorable conditions for O-methylation of the ortho-substituted
hydroxyl group, converting it from the minor form to the dominant form. After this step
the meta and para groups were deprotected yielding the desired methyl benzoate.121
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Molecular regioselective predictability permitted for strategic planning to be used
to ameliorate the inadequate yield of the desired product by revealing that the reaction
conditions could be manipulated effectively to obtain the preferred construct. The ability
to anticipate pitfalls in organic chemical synthesis in this approach is vital to generating
the enantiomerically pure compounds required for pharmaceutical purposes and
concomitant production of adequate quantitative yield of the preferred stereo- &
regioselective product.122

The Major Advantages of HuaCat®
A preponderance of chemical substances that are molded and fragmented in
metabolic processes are optically active, and typically one specific enantiomer is shaped
in these processes; therefore, affording their abundance in nature.123 As a consequence of
the stereoselectivity associated with these processes in biological systems, it is not
mutually exclusive that it has also been observed on numerous circumstances that the
physiological activity expressed of a particular compound resides almost exclusively in
one of its optically active forms.124 The scientific and the practical significance of
methods for the research of specific optical isomers is relatively discernable.
The conventional chemical resolution system agonizes from the detriment of
yielding theoretical maximums of approximately 50% of the required optically active
isomer established by the racemic starting material. Treatment of the racemic mixture
with reagents of biological origin such as, microbiological enzymes, is an alternate
procedure that exists with relatively similar disadvantages.124 Divergence from this
regularity stems from the induction of an asymmetric synthesis that can theoretically
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result in yields approaching 100% of simply one enantiomer.125 Its significance is
manifested through the copious amounts of journal articles and chemical literature
demonstrating its magnitude.126 The description of laboratory results with reactions
producing one diastereoisomeric pair of a given structure is termed “stereoselective
syntheses,” and is sometimes referred to as, “asymmetric syntheses” in some circles.124
In parallel with the aforementioned concept that stereoselective reactions are
critically important in the field of organic chemistry. There are numerous accounts of
pharmaceutical therapeutics that have complex stereochemistry as key parts of their
pharmacophore.127-130 Researching methods for forming selective carbon-carbon
asymmetric bonds can have a large impact on drug discovery131 and human health.9
Considering this rational and that organocatalysis has gained the notice of the
synthetic pharmaceutical population. Research in this area has been stimulated by
stereoselectivity132 that can be produced in mild reaction conditions,133 with relative ease
of execution,134 and extensive array of feasible chemical transformations.135 Proline (Pro)
as an organocatalyst,136 has drawn noteworthy consideration in this area, markedly in the
role of facilitating aldol reactions.137 Pro has been used in the development of broad
scope aldolase antibodies that show very high enantioselectivities138 and it has been
postulated that they proceed via an enamine mechanism.139 Asymmetric small-molecule
aldol catalysts that use an enamine mechanism have great potential in the discipline of
organic chemical synthesis.140
Explicitly, the proposed mechanism for Pro catalysis follows the ZimmermanTraxler model for aldol reactions.141 This model suggests that the transition states of
certain aldol reactions have six membered intermediates that display chair confirmations
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facilitated by intramolecular dipole-dipole bonding.142 Figure 20 displays a general view
of how the chair confirmation may look.

Figure 20 - Zimmerman model for chair confirmation transition state

It is well documented that proline can undergo an assortment of reactions with
aldehydes that are aliphatic143 and aromatic144 compounds. Although there are ketone side
products this can be ameliorated with high concentration of a polar aprotic solvent, such
as acetone or Dimethyl sulfoxide (DMSO);145 however, this is problematic due to the
high cost of solvents and the environmental difficulties that come with the removal of
waste products.146 Moreover, the yield is still relatively low at 68% as a racemic
mixture.145
The established reaction stereochemistry in the Zimmerman model, E-enolates (or
trans for relative stereochemistry) have a tendency to generate anti-addition products with
the two groups of higher priority added to opposite sides (or faces) of the newly formed
carbon bond, essentially resulting in a reduction in bond order but a rise in the number of
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substituents. In direct contrast, Z-enolates (cis) have a higher reaction propensity towards
syn-addition products. The factors that control selectivity are the preference for placing
substituents equatorially in six-membered transition states and the avoidance of synpentane interactions, respectively (See figure 21 for proposed mechanism of interaction).
Generally the use of metals such as lithium and boron are used for this enolate
mechanism of aldol reactions and thereby reliably follow the Zimmerman–Traxler
model.147 However on occasion metals can be relatively unpredictable with respect to
their stereochemical results.148

Figure 21 - Proposed mechanism for Proline aldol reaction with transition state chair confirmation

The exploration of Pro as an organocatalyst was initiated due to: (1) its nature for
being an optically active pyrrolidine derivative. (2) The asymmetric carbon atom is in the
same molecule next to the functional groups. (3) The asymmetric carbon atom is in a
five-membered ring. The cyclic system provides amplified rigidity that typically
augments the optical rotatory power; therefore, concomitant rise in the stereoselectivity
of the asymmetric reagent can be anticipated. (4) The facile addition of the optically
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active reagent on various positions of the reacting symmetrical construct facilitating
differentiation of identical groups. This is facilitated by the addition of various functional
group substituents to impart a transient disposition with respect to reaction conditions. (5)
Furthermore, the isoelectric point of proline at pH 6.30 is ideal for limiting the formation
of unwanted side products such as ketols.124
The exploration of Pro as an organocatalyst was initiated due to: (1) its nature for
being an optically active pyrrolidine derivative. (2) The asymmetric carbon atom is in the
same molecule next to the functional groups. (3) The asymmetric carbon atom is in a
five-membered ring. The cyclic system provides amplified rigidity that typically
augments the optical rotatory power; therefore, concomitant rise in the stereoselectivity
of the asymmetric reagent can be anticipated. (4) The facile addition of the optically
active reagent on various positions of the reacting symmetrical construct facilitating
differentiation of identical groups. This is facilitated by the addition of various functional
group substituents to impart a transient disposition with respect to reaction conditions. (5)
Furthermore, the isoelectric point of proline at pH 6.30 is ideal for limiting the formation
of unwanted side products such as ketols.124
Notwithstanding Pro’s effective enabling of organocatalytic activity, it has its
limitations.149 Accordingly, an assortment of Pro mimetics are concomitantly being
designed to furnish enhanced reactivity profiles.150 Two frequently commissioned classes
of note are the tetrazoles,151-154 shown in figure 22A, and sulfonamides155-160 in figure
22B. The use of 4-trans-hydroxyproline derivatives is prevalent in organocatalysis;161
however, only one enantiomer of trans-hydroxyproline is facilely accessible which poses
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another obstacle to these substrates; therefore, more considerably diverse structures are
required for facile use.

Figure 22 – Tetrazole (A); Sulfonamides (B)

In addition, organocatalyzed reactions containing proline or proline surrogates
utilize polar solvents such as DMF and DMSO.157 Although universally employed in
research laboratories, their polarity generates additional obstacles for product separation
and purity. The industrial application of nonpolar solvents are valuable because they
provide reliable phase splits with water and can be recycled to a limited scale.162-166
The use of solvents typically accounts for approximately 80% of the mass of a
reaction in a conventional pharmaceutical batch chemical operation.166 Furthermore,
solvents are one of the principal players in the overall toxicity profile of a reaction
procedure.55 Yet, for synthetic organic chemists, solvents are classified as the medium in
which a reaction takes place and are not typically included as reactants in the
stoichiometric sense because the focus is in the formation of the anticipated compound,
not in the instrument by which it is carried out.166
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It must be noted that the need for inexpensive materials is part of the bottom-line
to any industrial and laboratory budget; therefore, proline mimetics should be reasonably
priced and readily accessible in both enantiomeric forms. Thus, the development of a
pragmatic solution for these tasks is persistently explored. However, there is a highly
practical and readily available proline surrogate called HuaCat®, developed by Dr. Rich
Carter of Oregon State University. It displays enhanced solubility properties in
conventional nonpolar organic solvents.167 HuaCat® is a proline mimetic sulfonamidebased catalyst.
HuaCat® has proven to be an effective catalyst for asymmetric aldol reactions
(A), a reaction where the enolate of an aldehyde or ketone is alkylated at the α-carbon by
a carbonyl of another molecule producing a β-hydroxy carbonyl compound with two
newly formed stereocenters,167 (figure 23A). HuaCat® can also mediate Mannich
reactions (B), an organic reaction which consists of an amino alkylation of an acidic
proton placed next to a carbonyl functional group by formaldehyde and a primary or
secondary amine or ammonia,168 (figure 23B). HuaCat® facilitates these reactions with
high stereoselectivity in aqueous conditions. Additionally, intramolecular Michael
additions (C), or cyclization of keto sulfones are also facilitated by HuaCat®, allowing
for the synthesis of five and six-membered rings with good yield and stereoselectivity,169
(figure 23C).
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Figure 23 - HuaCat® facilitated asymmetric reactions: (A) Aldol reaction (B) Mannich reaction (C)
intramolecular Michael addition

Since the goal of various research studies is to synthesize compounds with highly
accurate stereo specificity through chiral affects from catalysts, reagents, and inexpensive
solvent systems. It is prudent to discover more mechanistic avenues for selective addition
of C-C Asymmetric bonds.
The major purpose of this experiment is to substitute select moieties on the Hua
Cat catalyst with different electron withdrawing/donating groups and observe their
Asymmetric induction of Carbon bonds in aqueous conditions. The hypothesis for the
proposed research is that the substitution of the current alkyl moiety with a trifluoro,
iodo, or dodecane functionality, in the Ortho position rather than the Para position, can
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offer another mechanism and increase catalytic yield of stereospecific compounds in
aqueous conditions for a wider range of substrate starting materials. (see figure 24 for
product structures)

Figure 24 - Desired products

We hope to observe the effectiveness of the proposed catalyst through:
First, synthesizing the proposed compounds in high yield. Second, characterization of the
compounds synthesized. Third, the use of the various catalysts in chemical reactions to
observe their effectiveness relative to current compounds in use as reagents for chemical
Asymmetric induction. The search for novel catalytic reagents is highly desired; with the
aforementioned experiments we can preferentially formulate chemical reactions with one
stereoisomer over another by broadening the chiral features that affect asymmetrically
induced chemical reactions.
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CHAPTER TWO
MATERIALS AND METHODS

General
All reactions involving air- and moisture –sensitive compounds were carried out
under a dried argon (Ar) atmosphere with standard Schlenk and vacuum-lines. All
glassware was oven dried at ≥ 110o C for ≥ 6hrs or flame dried under vacuum and purged
with Ar three times. Reactions were performed in Teflon tape sealed round bottom flasks
and pigment-free, filler-free septa sleeve stoppers with reactions mixtures ensuing
agitation via oven dried magnetic stir bars. Chemicals and solvents were purchased from
commercial suppliers at ≥98.9% purity as certified ACS reagent grade from Fisher
Scientific (Fair Lawn, NJ) and Sigma Aldrich (Milwaukee, WI), without further
purification. Thinlayer chromatography (TLC), was performed on silica gel plates
(Merck, silica gel 60 F254). Concentration of compounds was accomplished using a Büchi
Rotary Evaporator (Rotovap) at appropriate solvent conditions with reduced atmospheric
pressure and water bath at an average temperature of 40o C. Flash column
chromatography was carried out with Grace Discoveries Reveleris flash purification
system with Reveleris® silica gel with an average particle size of 39.1 μm and a pore
diameter of 65 angstrom. All compounds were visualized by irradiation with UV light
and/or by treatment with a solution of phosphomolybdic acid (25 g), Ce(SO4)2H2O (10
g), concentrated H2SO4 (60 mL), and H2O (940 mL) followed by heating or by treatment
with a solution of p-anisaldehyde (23 mL), concentrated H2SO4 (35 mL), acetic acid (10
mL), and ethanol (900 mL) followed by heating. 1H NMR spectra were measured on a
Bruker AM-300 spectrometer in CDCl3 or acetone-d6 with tetramethylsilane (TMS) as
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the internal standard, where J (coupling constant) values are estimated in Hz. Spin
multiples are given as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), and br
(broad).
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CHAPTER THREE
SYNTHETIC STRATEGY, RESULTS, & DISCUSSION

Design Strategy
The main goal of the project is to make ortho-substituted HuaCat® derivatives
with strong electron-withdrawing functional groups. Although a method has been
established for making HuaCat® and other para-substituted HuaCat® derivatives, there is
currently no reliable method for making the ortho-substituted analogous structures. The
few relevant methods in the literature do not account for strong electron-withdrawing
effects of the sulfonamide substrates rendering them much less nucleophilic than an
unsubstituted sulfonamide. The development of the organocatalytic HuaCat® analogues
began with the base proline structure and the attempted manipulation of the
intramolecular forces that are displayed in the chair transition state model seen below in
figure 25. The project had 3 different design phases based on the results of the respective
previous designs.

Figure 25 - Projected transition states of desired products
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Our initial experiments were based on the original synthetic route for a
mainstream peptide coupling reaction with three marked regions of divergence that
would serve to precede us through the design of further analogues after the initial brand
originated from the master model of HuaCat®. The three building blocks, in figure 26,
represent the areas where manipulation will occur. First, the substitution of an electron
withdrawing/donating group at position 7 of building block 1. Second, is the
rearrangement of the sulfonamide from para to ortho, or its movement from position 3 to
position 5. Lastly, is the varying protecting groups at position 17 of building block 3.

Figure 26 - Three building block regions of diversification

In the first design phase, we conducted base catalyzed break down of a larger
molecule (compound 1/saccharin) in preparation for subsequent nucleophilic substitution
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of the ester moiety to an activated iodododecane electrophile. Eventually leading to a
standard peptide coupling on the activated Nitrogen (N) of the sulfonamide moiety to the
electrophilic carbonyl portion of a Carboxybenzyl-protected L-proline (Cbz-L-Pro-OH),
as outlined in the second step of figure 27. However, after attempted characterization of
the final product, we concluded that this method was not efficient due to a lack of
appreciable yield; therefore this route was abandoned and we proceeded on to our next
phase of synthetic design.

Figure 27 - phase 1 steps

In the second design phase, although it was understood that an ortho-substituted
version would be appreciably less nucleophilic than the para-substituted compounds like
HuaCat I & II. Moreover, it was noted that the steric hindrance would also be
problematic to nucleophilic activation. However, to inductively rule out all possible
barriers to success, we proceeded with the initial attempt utilizing similar reaction
conditions to couple analogous starting materials to make the desired target compounds.
As can be seen in figure 28, standard peptide coupling conditions were attempted.
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Figure 28 - Standard peptide coupling conditions

Essentially, this phase involved the purchase of sulfonamide, and corresponding
carboxylic acid (Pro), starting materials to couple into the target compounds. Using NMR
analysis of our product we concluded that the second design phase proved to be
unsuccessful. We theorized that the CF3 moiety created a heightened electronwithdrawing effect that deactivated the N portion of the sulfonamide nucleophile, thereby
hindering its nucleophilic capability and preventing the reaction from moving forward.
This lead to the use of various coupling agents under the same reaction conditions to rule
out the effectiveness of the reagents. This also comprised alternating various types of
organic bases to ensure nucleophilic activation through deprotonation. This ruled out the
propensity for one base over another under certain reaction conditions. It eventually came
to include manipulation of reaction conditions in the form of temperature control, protic
vs aprotic solvent usage, and various other strategies outlined in Tables 1 & 2
referencing figure 30.
Despite copious manipulation of reaction procedure support elements, we were
unable to ascertain the desired product and therefore aborted our second phase of
experimental design strategy. Speculating that the ortho-substituted sulfonamide was
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much less nucleophilic than the para-substituted sulfonamide, we moved towards an
alternate design strategy. One that utilized the sulfonamide substrate as the electrophile
rather than the nucleophile. In this phase, Thionyl chloride substituted starting material
was coupled with the corresponding amido-substituted Prolinamide (Cbz-L-Pro-NH2), as
seen in figure 29.

Figure 29 - Acid Chloride coupling reaction

As aforementioned, we attempted many different ways to construct the target
derivatives. Some of the attempts included substrate changes from sulfonamides as
nucleophiles to amides as nucleophiles, activating carboxylic acids for nucleophilic
attack with many different peptide coupling agents170 (EDCI, HOBt, HATU, etc.) and
converting them to acid chlorides, the use of many different bases from mild to very
strong, and increased reaction temperature with expanding reaction times.171-175 To date,
we have not been successful in constructing the target compound in appreciable yield.
The low yield of the product led to our third experimental design phase that
involved a more indirect route through the use of a thiol substituted Benzene ring. Taking
advantage of the increased electrophilic nature of the Thio-amine, relative to the
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sulfonamide, we surmised that coupling the Carboxylic acid would be more feasible.
Thereby allowing for higher yield of the target compound. After which we could oxidize
the sulfur portion of the sulfo-amide converting it to the desired sulfonamide using a
well-documented standard method with m-Chloroperoxybenzoic acid (MCPBA).176, 177
We have attempted to synthesize HuaCat® ortho-substituted derivatives by
reaction schemes outlined in figure 30 following Tables 1 & 2 reaction conditions. A
more detailed explanation of each step will be presented in the experimental section.
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Figure 30 - General scheme for the formation of the desired organocatalysts
Table 1 - Sample of attempted reactions to achieve the desired final organocatalyst

Table 2 - Details of reaction conditions A-E
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Examination of Results & Discussion
The prevailing theory was that the common dynamics utilized to synthesize the
original compound would again be applied to produce the analogue. Therefore, our initial
protocol demonstrated as much; however, with different starting materials. Utilizing base
catalysis that encompassed Saccharin as our starting material, with subsequent standard
peptide coupling conditions170 (EDC, DMAP, in DMF) of compounds that included Cbzproline.178 Followed by deprotection using activated charcoal as seen in figure 31.
However, this synthetic route was unsuccessful when we arrived at the third step
that required the coupling of the Proline amino acid to the sulfonamide. Potentially due to
the steric hindrance of the new position of the sulfonamide on the benzene ring. Rather
than postulating the results with further experimentation we decided to explore other
synthetic routes.
In light of this, we developed another unrelated synthetic scheme (Figure 32).
First, a chemo-selective alkylation of a thiol using NaH followed by the formation of the
thiol chloride and nucleophilic addition of ammonia should afford the
benzenesulfamine.179 The rationale behind this is that the thiohydroxylamine does not
have the same acidic nature seen in the sulfonamide, potentially allowing for more
reactivity that was hindered in previous experiments. We reasoned that the increased
reactivity should tolerate the addition of the protected Proline-OH or Proline acid
chloride peptide coupling.180 Lastly, the oxidation of the thiol to the sulfone using mchloroperoxybenzoic acid (MCPBA) yielding the desired product, before amino
deprotection with Pd178 on the Pro, is well documented.176

46

Figure 31 - Initial protocol for synthesis
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Figure 32 - Newly identified synthetic route to overcome the limitations of previous synthetic
attempts

Conclusion
Although a method has been established for making HuaCat® and other parasubstituted HuaCat® derivatives, there is currently no method for making the orthosubstituted analogous structures. The main goal of the project was to make HuaCat®
derivatives with strong electron-withdrawing functional groups as a para-substituent.
However we were unsuccessful at achieving this goal and are currently searching for
other methods of obtaining this but are still deliberating on viable methods to accomplish
this feat. The product can be synthesized via these routes however, the yield varies from
2-9 %. Unfortunately making it an undesirable amount relative to the cost, our test results
vis-à-vis the desired standards for lucrative use in the laboratory.
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Experimental Section

Figure 33 - Step one for production of compound 1

1. Sodium hydride (85% suspension in mineral oil, 280 mg, 2.5 mmol) was added
to a solution of 2-(trifloromethyl)benzenethiol (500 mg, 2.8 mmol, 1 equiv) in
anhydrous THF (5 mL). The mixture was stirred at room temperature for 10 min
and treated with benzyl bromide (480 mg, 2.8 mmol, 1 equiv) for 1 h. After
treatment with acetic acid, the reaction mixture was diluted with EtOAc and
brine. The organic phase was separated and dried over Na2SO4. The filtrate was
concentrated in vacuo and the resulting residue was purified by flash column
chromatography on silica gel to obtain product. Product weight after purification:
2.017 mg. 2.017/268.30=0.0075; 1.438/178.17=0.0081; 0.0075/0.0081=0.9259
0.9259*100=92.59% yield.
Table 3 - Step one quantities

Compound

MW (g/mol) D (g/mL) mmol

2-(Trifloromethyl) benzenethiol

178.17

1.438

Sodium Hydride

23.9971

1.396

THF

72.11

0.948

Benzyl bromide

171.03

1.35
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8.1

mg

mL Equiv

1.43

1.0

280.6

15.8

480.0

1
2.5

5.61

0.5

2

2

Figure 34 - Step two for compound 2

2. Compound 1 (1.77 mg, 2 mmol) was dissolved in CH2Cl2 (2 mL) and SO2Cl2 (2
mL, 8 mmol) was added. The mixture was stirred at room temperature for 10 h and
then concentrated to dryness. To the residue was added 7 M NH3 in MeOH 10 mL).
The mixture was stirred 2 h at room temperature, then diluted with water, extracted
with EtOAc, washed with brine, dried (MgSO4), and concentrated to dryness. The
residue was dissolved in a minimum amount of EtOAc and reprecipitated with
hexane. The resulting solid was collected by filtration to afford the title compound as
a light tan solid. Product weight after purification: 189.2 mg. 189.2/193.19=0.9793;
475/268.3=1.7704; 0.9793/1.7704=0.5532; 0.5532*100=55.32% yield.

Table 4 - Step two quantities

Compound

MW (g/mol) D (g/mL) mmol

Compound 1

268.3

Sulfuryl chloride

118.97

Ammonia in MeOH

50.07

anhydrous DCM

41.05

1.631

0.786

50

mg

mL

Equiv

1.77

475.0

1

8.85

1053.1 0.645

5

3.54

177.3

10

2

1.770

0.5

0.89

Figure 35 - Step 3 for compound 3

3. EDCI (176 mg, 1.14 mmol) and 4-dimethylaminopyridine (189 mg, 1.55 mmol)
were dissolved in acetonitrile (5 mL). The solution was then added to a mixture of
compound 2 (200 mg, 1.04 mmol) and Cbz-L-Proline (283 mg, 1.14 mmol) in a
reaction flask cooled to 0° C. This reaction mixture was allowed to warm to room
temperature and stir for 24 hours at which time it was diluted with EtOAc (50 mL)
and washed with a saturated NaHCO3 solution (3x30 mL). The combined aqueous
layers were back extracted with EtOAc (2x30 mL). All organic layers were
combined, dried over MgSO4, and concentrated to give 0.9507 mg of crude product
mixture which was purified via flash chromatography (silica gel, 1:1 hexane: EtOAc)
to give compound 14 ( mg, % yield) as yellow oil. Product weight after purification:
38.1 mg. 38.1/424.44=0.0898; 200/193.19=1.0353; 0.089/1.0353=0.086; 0.086*100=8.6 %
yield.
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Table 5 - Step three quantities

Compound

MW (g/mol) D (g/mL) mmol

mg

mL Equiv

Cbz-L-Proline

249.27

1.14

283.9

1.1

EDCI

155.24

1.14

176.8

1.1

DMAP

122.17

1.55

189.7

1.5

Compound 3

193.19

1.035 200.0

Acetonitrile

41.05

0.786

0.57

1
1.13

0.5

To a stirred solution of Cbz-L-Proline (500 mg, 2.01 mmol) in Acetonitrile (2
mL), were added EDCI (342 mg, 2.21 mmol), DBU (360 mg, 2.41 mmol), HOBt (338
mg, 2.21 mmol), and 2-(Trifloromethyl) benzenesulfonamide) (451 mg, 2.01 mmol),
then left to stir for 3 days respectively. Daily, EDC and HOBt were added again (about
60% of original equivalents). After TLC verification, 15 mL 1M Citric Acid was
introduced to the reaction mixture (to neutralize the base), and then washed with Brine (3
X ~40 mL). The dried (MgSO4) extract was concentrated in vacuo (after filtration) then
purified by chromatography over silica gel, eluting with 5-10% EtOAc / Hexane.
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Figure 36 - Step four for compound 4

4. To a solution of Compound 3 (500 mg, or 1 eq.) in CH2Cl2 (3 mL) at 0 °C was
added m-CPBA (142 mg, or 1.8 eq.). After the mixture is stirred at 0 °C for 39 h, the
reaction is quenched with saturated aqueous Na2S2O3 and saturated aqueous
NaHCO3. The mixture was extracted with EtOAc, washed with saturated aqueous
NaCl, dried over anhydrous MgSO4, and concentrated to give the crude product
mixture which is purified via flash chromatography (silica gel, 1:1 hexane: EtOAc) to
give compound 14 (~59% yield) as a yellow oil.176, 177
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Various Attempted Experimental Procedures

Figure 37 - Previous experimental procedures, 1-6 reactions
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Figure 38 - Previous experimental procedures, 7-12 reactions
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Figure 39 - Previous experimental procedures, 13-18 reactions
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Typical procedure for the preparation of Compound 2:

Figure 40 – Experimental procedure for 2.

General procedure:
A mixture of saccharin (0.997 g, 5.5 mmol.) and sodium hydroxide (NaOH)
(0.5 g, 12.5 mmol.) in distilled water (25 ml) was heated to reflux (1 hr), cooled to room
temperature and acidified to pH = 4 (15% HCl). The reaction mixture was subjected to
cooling in freezer overnight and white flake-like product was filtered, washed with cold
water and dried to yield 1.06 g of the title compound (5.3 mmol. 97%) which was
recrystallized from a solution of MeOH and CHCl3 (1:1) at 40o C to obtain colorless
crystals.180, 181
Typical procedure for the preparation of Compound 3a:

Figure 41 – Experimental procedure for 3a
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General procedure:
To a mixture of Compound 2 (304 mg, 1.51 mmol) and N, N-Diisopropylethyl
amine (DIPEA) (214 mg, 1.66 mmol) that were dissolved in 13 mL of acetonitrile, was
added 1-iodododecane (492 mg, 1.66 mmol) at 85o C. The mixture was stirred overnight,
then the reaction mixture was allowed to come to Room temperature. The mixture was
then concentrated in vacuo to remove acetonitrile and then diluted with EtOAc (20 mL)
and washed with 10% KHSO4 (2x5 mL), NaHCO3 sat (2x5 mL) and brine. The organic
extracts were dried over Na2SO4, filtered and concentrated in vacuo. The crude was
purified by flash column chromatography (5-20% EtOAc-hexanes) to yield 72 mg (0.10
mmol, 81%) of 3a as a white solid.182
Typical procedure for the preparation of Compound 4a:

Figure 42 – Experimental procedure for 4a.

General Procedure:
A mixture of EDCI (176 mg, 1.14 mmol) and 4-dimethylaminopyridine (189
mg, 1.55 mmol) were dissolved in acetonitrile (5 mL). The solution was then added to a
mixture of compound 1 (200 mg, 1.04 mmol) and Z-Pro (283 mg, 1.14 mmol) in a
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reaction flask cooled to 0° C. The reaction mixture was allowed to warm to room
temperature and stir for 24 hours at which time it was concentrated in vacuo to remove
acetonitrile, then diluted with EtOAc (50 mL) and washed with a saturated NaHCO3
solution (3x30 mL). The combined aqueous layers were extracted with EtOAc (2x30
mL). All organic layers were combined, dried over MgSO4, and concentrated to give
0.9507 mg of crude product mixture which was purified via flash chromatography (silica
gel, 10:1 EtOAc:hexane) to give compound 4 (38.1 mg, % yield) as yellow oil.183 Product
weight after purification: 38.1 mg.
Typical procedure for the preparation of Compound 4b:

Figure 43 – Experimental procedure for 4b.

General experimental procedure for N-acylation of sulfonamides with anhydrides:
To a mixture of Cbz-L-Proline (1.0 mmol) and Benzoic anhydride (C6H5CO)2O
(1.5 mmol), 3 mol % of anhydrous ZnCl2 (1M in ether) was added and the reaction
stirred in 20 mL DCM to allow for anhydride to form, then add Sulfonamide to reaction
mixture and was allowed to stir for the given time. After completion of the reaction
(monitored by TLC), the reaction mixture was diluted with dichloromethane and washed
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with water and brine solution. The combined organic layers were dried over K2SO4 and
evaporated in vacuo. The crude compound was purified by column chromatography
(hexanes and EtOAc) to afford the corresponding N-acylated product.
General experimental procedure for N-acylation of sulfonamides with carboxylic acids:
To a stirred solution of 5 mol % anhydrous ZnCl2 in anhydrous
dichloromethane, carboxylic acid (1.2 mmol) was added followed by the addition of
benzoic anhydride (1.2 mmol) under an Argon atmosphere at room temperature. After
10 min, a solution of sulfonamide in CH2Cl2 was added and the resulting reaction
mixture was stirred for the given time. After completion, the reaction mixture was
washed with water then brine and the combined organic layers were dried over Na2SO4
and evaporated in vacuo. The crude compound was purified by column chromatography
(hexanes and EtOAc) to afford the corresponding N-acylated product.174
Typical procedure for the preparation of Compound 4c:

Figure 44 – Experimental procedure for 4c.

General procedure:
Under an Argon atmosphere, a mixture of Fmoc-Proline and Benzoic anhydride
(C6H5CO)2O, in THF (~8 ml) was stirred at 60°C and treated with 96% sulfuric acid (5
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mol%) was added and the reaction stirred to allow for anhydride to form. The solution
was maintained at 60°C for 4 hours until reaction was judged complete by TLC. Then
Benzenesulfonamide (300 mg, 1.33 mmol), was added to reaction mixture drop-wise
and was allowed to stir overnight @ 60oC. After completion of the reaction (monitored
by TLC), the solvent was removed by distillation and then the solution was cooled to
24°C. Water (10–15 ml) was added dropwise to form a precipitate. The resulting mixture
was stirred for 1 h at 20°C and then filtered. The crude solid was washed with deionized
water (5–10 ml) and then dried in vacuo under nitrogen at 50°C for 18 h. Weight of white
crystalline solid was 238 g. The reaction mixture was diluted with dichloromethane and
washed with water and brine solution (3x15 mL). The combined organic layers were
dried over Na2SO4 and evaporated in vacuo. The crude compound was purified by
column chromatography (10:1, EtOAc and hexanes) to afford the corresponding Nacylated product.173
Typical procedure for the preparation of Compound 4d:

Figure 45 - Experimental procedure for 4d using Pyridine with acid chloride.
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General Procedure:
Boc-Proline-NH2 (2.04 mmol, 438 mg) was dissolved in 50 mL of pyridine; to
this solution was added 2-(Trifluoromethyl) benzene sulfonyl chloride (2.04 mmol,
315μL). This mixture was stirred for 1–2 h and then left overnight without stirring. After
completion of the reaction, crushed ice was added to this mixture and the mixture was
stirred again to obtain a solid crude product; if the mixture was slightly acidified, we did
not obtain any product. This crude product was washed with dichloromethane and ice
cold water. The product was further purified using column chromatography to obtain
crystals of compound.172
Typical procedure for oxalyl chloride catalyzed preparation of Compound 4b:

Figure 46 - Experimental procedure for 4b using oxalyl chloride.

General Procedure:
In a reaction mixture Cbz-L-pro (1.1 mg, 4.4 mmol) was suspended in dry DCM
(10 mL) under Argon atmosphere. To this solution, oxalyl chloride (4.1 mL, 48 mmol)
was slowly added and the mixture was stirred for 2 h (with TLC observation). Gas
evolution was observed, and the system was allowed to stir at room temperature for 28 h.
The system was connected to another flask of 6 M NaOH to react with the HCl gas that
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is formed from the reaction of the Reactants. The DCM was removed under reduced
pressure and the residue was suspended again in dry CH2Cl2 (10 mL). After addition of
triethylamine (0.74 mL, 5.2 mmol) to the reaction mixture, 2-(Trifluoromethyl)
benzene sulfonamide (1.2 mg, 5.2 mmol) in DCM (5 L) was slowly added. The reaction
mixture was stirred at room temperature for 4 h and then the mixture was suspended in
water to remove impurities. The organic phase separated and the solvent was removed
under reduced pressure to obtain a brownish viscous oil.184
Typical procedure for Amide peptide coupling reactions by various organocatalysts:

Figure 47 - Procedure for 4b using HATU

General Procedure:
To a stirred solution (after 4.0 hrs of stirring) of Cbz-Pro-OH (500 mg, 2.01
mmol) & triethylamine (0.300 mL, 2.21 mmol) in THF (2 mL), was added HATU (838
mg, 2.2 mmol). After 1hr a mixture of 2-(Triflouro) benzene sulfonamide (677 mg,
3.01 mmol) with 60% NaH (136 mg, 3.3 mmol) in THF (2mL) was added and left to stir
for 2hrs respectively. After TLC verification, 5 mL 1M HCl was introduced to the
reaction mixture (to neutralize the base), and then washed with brine (3 X ~40 mL) and
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the organic layer was washed again with 1M NaOH. The dried (Na2SO4) extract was
concentrated in vacuo (after filtration) then purified by chromatography over silica gel,
eluting with 1-50% EtOAc/hexanes.185

Figure 48 – Procedure for 4b using HOBt

General Procedure:
To a stirred solution of Cbz-L-Pro (0.166 g, 0.670 mmol) in THF (7 mL), were
added EDCI (0.103 g, 0.670 mmol), HOBT (0.090 g, 0.670 mmol), and 2-(triflouro)
benzene sulfonamide (0.300 g, 1.33 mmol) in THF (7 mL), then left to stir for 5 days
respectively. After TLC verification, 15 mL 1M HCl was introduced to the reaction
mixture (to neutralize the base), and then washed with brine (3 X ~40 mL). The dried
(Na2SO4) extract was concentrated in vacuo (after filtration) then purified by
chromatography over silica gel, eluting with 5-20% EtOAc/hexanes.186
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Figure 49 - Procedure for 4e using PyBOP and Iodo-benzene sulfonamide

General Procedure:
To a stirred solution (after 1.0 hr of stirring) of Cbz-Pro-OH (200 mg, 0.8 mmol)
& DIPEA (0.4 mL, 2.4 mmol) in THF (2 mL), was added PyBOP (440 mg, 0.89 mmol).
After 1hr a mixture of MTBD (0.150 mL, 0.96 mmol) 2-iodobenzene sulfonamide (216
mg, 0.96 mmol) was added. After 10 min another equivalent of PyBOP was added and
left to stir overnight, respectively. After TLC verification, 5 mL 1M HCl was introduced
to the reaction mixture (to neutralize the base), and then washed with brine (3 X ~40
mL). The dried (Na2SO4) extract was concentrated in vacuo (after filtration) then purified
by chromatography over silica gel, eluting with 10% MeOH/DCM.187

Figure 50 - Procedure for 4d using HBTU
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General Procedure:
To a stirred solution (after 20 min of stirring) of Boc-Pro-OH (300 mg, 1.39
mmol) & DIPEA (0.728 mL, 4.18 mmol) in THF (2 mL), was added HBTU (581 mg,
1.53 mmol). After 1/2 hr, 2-(trifluoro) benzene sulfonamide (313 mg, 1.39 mmol) was
added and left to stir for 2hrs respectively. Reaction mixture was concentrated then
extracted using chloroform. After TLC verification, 40 mL 1M HCl was introduced to
the reaction mixture (to neutralize the base), and then washed with brine (3 X ~40 mL).
The dried (Na2SO4) extract was concentrated in vacuo (after filtration) then purified by
chromatography over silica gel, eluting with 100% EtOAc. Product mass crude 976
mg.188

Figure 51 - Procedure for 4d using TBAHS and sulfonyl chloride through acid catalysis.

General Procedure:
To a stirred solution of Boc-L-Pro-NH2 (300 mg, 1.21 mmol) and NaOH (23 mg,
0.580 mmol) in THF (4 mL), were added tetrabutylammonium hydrogen sulfate
(TBAHS) (40 mg, 0.121 mmol), and 2-(triflouromethyl) benzene sulfonyl chloride
(0.37 mL, 2.4 mmol) in DCM (2 mL), then left to stir for 2 days respectively. After TLC
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verification, 5 mL 1M HCl was introduced to the reaction mixture (to neutralize the
base), and then washed with brine (3 X ~40 mL). The dried (Na2SO4) extract was
concentrated in vacuo (after filtration) then purified by chromatography over silica gel,
eluting with 10% MeOH/DCM.189

Figure 52 - Procedure using NaH and sulfonyl chloride

General Procedure:
To a stirred solution of THF and sodium hydride (NaH) (50 mg, 1.22 mmo),
Cbz-L-Pro-NH2 (305 mg, 1.22 mmol) was added at 0o C. The solution was allowed to
stir for 1 hr at rt and then 2-(trifluoromethyl) benzene sulfonyl chloride (315 μL, 2.0
mmol) was added drop-wise at 0o C, then allowed to stir for 1 hr. The Reaction mixture
was allowed to come to rt and left overnight. Then concentrated to remove THF and rediluted with EtOAc. It was then separated using brine, water, and EtOAc. The organic
layer was dried using Na2SO4 anhydrous, then concentrated in vacuo. The product was
weighed and purified using flash chromatography.190
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